Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byGlaxoSmithKline
Price$720M
Date4/2008
TermsCash

General Information

Websitesirtrispharma.com
CategoryBioTech
Phone617-252-6920
Emailinfo@sirtrispharm...
Employees
Founded2004
DescriptionBiopharmaceutical Company

Offices

Cambridge, USA
200 Technology Square
Suite 300
Cambridge, MA, 02139
USA

People

Co-founder/BOD

Funding

Tags

Sirtris Pharmaceuticals

Sirtris Pharmaceuticals (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes.

via: Sirtris

Recent Milestones

Videos

Screenshots

Sirtris Pharmaceuticals screenshot
Above: Sirtris Pharmaceuticals Screenshot -- #1
Uploaded: 6/12/09
Sirtris Pharmaceuticals screenshot
Above: Sirtris Pharmaceuticals Screenshot -- #2
Uploaded: 6/12/09

Traffic Analytics

Quantcast

Livegraph

Compete

Sirtrispharma

Sources

  1. GlaxoSmithKline to acquire Sirtris Pharmaceuticals, a world leader in 'Sirtuin' research and development (phx.corporate-ir.net) [edit]
  2. HBR case article (sirtrispharma.com) [edit]
  3. Sirtris closes $13 million financing (boston.bizjournals.com) [edit]
  4. Sirtris Pharmaceuticals closes $27M second round (boston.bizjournals.com) [edit]
  5. Sirtris pockets $37M in venture funds (fiercebiotech.com) [edit]
Edit This Page
Last Edited 3/6/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy